<p>The purpose of this book is to provide a general guide to statistical methods used in the pharmaceutical industry, and to illustrate how to use S-PLUS to implement these methods. Specifically, the goal is to: *Illustrate statistical applications in the pharmaceutical industry; *Illustrate how the
Statistics in the pharmaceutical industry
β Scribed by Buncher, Charles Ralph; Tsay, Jia-Yeong
- Publisher
- CRC Press
- Year
- 2019
- Tongue
- English
- Leaves
- 497
- Series
- Biostatistics
- Edition
- 3rd ed
- Category
- Library
No coin nor oath required. For personal study only.
β¦ Table of Contents
Content: Introduction to the Evolution of Pharmaceutical Products
<
i>
C. Ralph Buncher and Jia-Yeong Tsay<
/i>
<
br>
Statistical Review and Evaluation of Animal Carcinogenicity Studies
<
i>
Karl K. Lin and Mirza W. Ali<
/i>
<
br>
The FDA and the IND/NDA Statistical Review Process
<
i>
Satya D. Dubey, George Y. H. Chi, and Roswitha E. Kelly<
/i>
<
br>
Clinical Trial Designs
<
i>
C. Ralph Buncher and Jia-Yeong Tsay<
/i>
<
br>
Selecting Patients for a Clinical Trial
<
i>
C. Ralph Buncher and Jia-Yeong Tsay<
/i>
<
br>
Statistical Aspects of Cancer Clinical Trials
<
i>
T. Timothy Chen<
/i>
<
br>
Recent Statistical Issues and Developments in Cancer Clinical Trials
<
i>
Weichung Joe Shih<
/i>
<
br>
Design and Analysis of Testosterone Replacement Therapy Trials
<
i>
Ted M. Smith<
/i>
<
br>
Clinical Trials of Analgesic Drugs
<
i>
Cynthia G. McCormick<
/i>
<
br>
Statistical Issues in HIV/AIDS Research
<
i>
Ronald J. Bosch and C. Ralph Buncher<
/i>
<
br>
The Wonders of Placebo
<
i>
C. Ralph Buncher<
/i>
<
br>
Active-Controlled Noninferiority/Equivalence Trials: Methods and Practice
<
i>
Irving K. Hwang<
/i>
<
br>
Interim Analysis and Bias in Clinical Trials: The Adaptive Design Perspective
<
i>
Qing Liu and Gordon Pledger<
/i>
<
br>
Interim Analysis and Adaptive Design in Clinical Trials
<
i>
Irving K. Hwang and K. K. Gordon Lan<
/i>
<
br>
A Regulatory Perspective on Data Monitoring and Interim Analysis
<
i>
Robert T. O'Neill<
/i>
<
br>
Complex Adaptive Systems, Human Health and Drug Response: Statistical Challenges in Pharmacogenomics
<
i>
Kim E. Zerba and C. Frank Shen<
/i>
<
br>
Phase IV Postmarketing Studies
<
i>
C. Ralph Buncher and Jia-Yeong Tsay<
/i>
<
br>
The Role of Contract Research Organizations in Clinical Research in the Pharmaceutical Industry
<
i>
Roger E. Flora and John Constant<
/i>
<
br>
Global Harmonization of Drug Development: A Clinical Statistics Perspective
<
i>
Peter H. van Ewijk, Bernhard Huitfeldt, and Jia-Yeong Tsay<
/i>
<
br>
Bridging Strategies in Global Drug Development
<
i>
Mamoru Narukawa and Masahiro Takeuchi<
/i>
<
br>
Design and Analysis Strategies for Clinical Pharmacokinetic Trials
<
i>
Lianng Yuh and Yusong Chen<
/i>
<
br>
Stability Studies of Pharmaceuticals
<
i>
Yi Tsong, Chi-wan Chen, Wen Jen Chen, Roswitha Kelly, Daphne T. Lin, and Karl K. Lin<
/i>
<
br>
When and How to Do Multiple Comparisons
<
i>
Charles W. Dunnett and Charles H. Goldsmith<
/i>
<
br>
Reference Intervals (Ranges): Distribution-Free Methods vs. Normal Theory
<
i>
Paul S. Horn and Amadeo J. Pesce<
/i>
<
h3>
Index<
/h3>
β¦ Subjects
Pharmacy;Statistical methods;Pharmaceutical industry;Statistical methods;Drugs;Testing
π SIMILAR VOLUMES
<p><p>This book examines statistical techniques that are critically important to Chemistry, Manufacturing, and Control (CMC) activities. Statistical methods are presented with a focus on applications unique to the CMC in the pharmaceutical industry. </p><p>The target audience consists of statisticia
<p><p>This book serves as a reference text for regulatory, industry and academic statisticians and also a handy manual for entry level Statisticians. Additionally it aims to stimulate academic interest in the field of Nonclinical Statistics and promote this as an important discipline in its own righ
A state-of-the-art handbook of statistical analysis for use in the pharmaceutical industry. Areas covered in this reference/text include: bioavailability, repeated-measures designs, dose-response, population models, multicenter trials, handling dropouts, survival analysis, robust data analysis, cate
A state-of-the-art handbook of statistical analysis for use in the pharmaceutical industry. Areas covered in this reference/text include: bioavailability, repeated-measures designs, dose-response, population models, multicenter trials, handling dropouts, survival analysis, robust data analysis.
The book reviews the historical context, definition, evolution, and application of containment technology, analyzes a variety of containment techniques in new and retrofitted construction, and examines Β«people protectionΒ» vs. Β«product protectionΒ» and the role of source-contamination in each. It also